Search hospitals > Michigan > Ann Arbor

C S Mott Children's Hospital

Claim this profile
Ann Arbor, Michigan 48109
Global Leader in Cancer
Global Leader in Neuroblastoma
Conducts research for Solid Tumors
Conducts research for Brain Tumor
Conducts research for Acute Lymphoblastic Leukemia
370 reported clinical trials
23 medical researchers
Photo of C S Mott Children's Hospital in Ann Arbor

Summary

C S Mott Children's Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Cancer, Neuroblastoma, Solid Tumors, Brain Tumor, Acute Lymphoblastic Leukemia and other specialties. C S Mott Children's Hospital is involved with conducting 370 clinical trials across 575 conditions. There are 23 research doctors associated with this hospital, such as Rajen Mody, MD, MS, Carl Koschmann, MD, Rama Jasty, and Emily B. Walling.

Area of expertise

1Cancer
Global Leader
C S Mott Children's Hospital has run 78 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Neuroblastoma
Global Leader
C S Mott Children's Hospital has run 72 trials for Neuroblastoma. Some of their research focus areas include:
MYC positive
Stage IV
MYC negative

Top PIs

Clinical Trials running at C S Mott Children's Hospital

Brain Tumor
Cancer
Neuroblastoma
Diffuse Intrinsic Pontine Glioma
Wilms Tumor
Testicular cancer
Brain Cancer
Leukemia
Solid Tumors
Acute Lymphoblastic Leukemia
Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Image of trial facility.

DAY101 vs. Chemotherapy

for Pediatric Brain Cancer

This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.
Recruiting2 awards Phase 3
Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at C S Mott Children's Hospital?
Where is C S Mott Children's Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does C S Mott Children's Hospital accept?
What awards or recognition has C S Mott Children's Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security